SWTX

SpringWorks Therapeutics
SWTX

Overview Fund Activity
Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

137 hedge funds and large institutions have $3.23B invested in SpringWorks Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 12 closing their positions.

Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
25
Increased
51
Reduced
46
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$183M
2
PA
2
Perceptive Advisors
New York
$357M
3
Bank of America
3
Bank of America
North Carolina
$36.8M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$279M
5
CCM
5
Consonance Capital Management
New York
$88.4M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$429M
2
O
2
OrbiMed
New York
$455M
3
DM
3
Deerfield Management
New York
$41.1M
4
Goldman Sachs
4
Goldman Sachs
New York
$10.3M
5
ACH
5
ArrowMark Colorado Holdings
Colorado
$84.2M
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
151
Concourse Financial Group Securities
Alabama
– – – –
3 4 5 6
7